Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Lactimicrobium massiliense gen. nov., sp. nov.; Anaerolactibacter massiliensis gen. nov., sp. nov.; Galactobacillus timonensis gen. nov., sp. nov. and Acidipropionibacterium timonense sp. nov. isolated from breast milk from healthy breastfeeding African women.

Togo AH, Diop A, Camara A, Kuete E, Konate S, Brevaut V, Des Robert C, Delerce J, Armstrong N, Roussel Y, Fournier PE, Thera MA, Raoult D, Million M.

New Microbes New Infect. 2019 Mar 23;29:100537. doi: 10.1016/j.nmni.2019.100537. eCollection 2019 May.

2.

Antibodies to Peptides in Semiconserved Domains of RIFINs and STEVORs Correlate with Malaria Exposure.

Zhou AE, Berry AA, Bailey JA, Pike A, Dara A, Agrawal S, Stucke EM, Ouattara A, Coulibaly D, Lyke KE, Laurens MB, Adams M, Takala-Harrison S, Pablo J, Jasinskas A, Nakajima R, Niangaly A, Kouriba B, Kone AK, Rowe JA, Doumbo OK, Thera MA, Patel JJ, Tan JC, Felgner PL, Plowe CV, Travassos MA.

mSphere. 2019 Mar 20;4(2). pii: e00097-19. doi: 10.1128/mSphere.00097-19.

3.

Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02A.

Berry AA, Gottlieb ER, Kouriba B, Diarra I, Thera MA, Dutta S, Coulibaly D, Ouattara A, Niangaly A, Kone AK, Traore K, Tolo Y, Mishcherkin V, Soisson L, Diggs CL, Blackwelder WC, Laurens MB, Sztein MB, Doumbo OK, Plowe CV, Lyke KE.

Malar J. 2019 Jan 18;18(1):13. doi: 10.1186/s12936-019-2637-x.

4.

Genetic polymorphisms with erythrocyte traits in malaria endemic areas of Mali.

Traore K, Konate S, Thera MA, Niangaly A, Ba A, Niare A, Arama C, Di Cristofaro J, Baby M, Picot S, Chiaroni J, Boetsch G, Doumbo OK.

PLoS One. 2019 Jan 4;14(1):e0209966. doi: 10.1371/journal.pone.0209966. eCollection 2019.

5.

School-aged children based seasonal malaria chemoprevention using artesunate-amodiaquine in Mali.

Thera MA, Kone AK, Tangara B, Diarra E, Niare S, Dembele A, Sissoko MS, Doumbo OK.

Parasite Epidemiol Control. 2018 Feb 7;3(2):96-105. doi: 10.1016/j.parepi.2018.02.001. eCollection 2018 May.

6.

Two complement receptor one alleles have opposing associations with cerebral malaria and interact with α+thalassaemia.

Opi DH, Swann O, Macharia A, Uyoga S, Band G, Ndila CM, Harrison EM, Thera MA, Kone AK, Diallo DA, Doumbo OK, Lyke KE, Plowe CV, Moulds JM, Shebbe M, Mturi N, Peshu N, Maitland K, Raza A, Kwiatkowski DP, Rockett KA, Williams TN, Rowe JA.

Elife. 2018 Apr 25;7. pii: e31579. doi: 10.7554/eLife.31579.

7.

Children with cerebral malaria or severe malarial anaemia lack immunity to distinct variant surface antigen subsets.

Travassos MA, Niangaly A, Bailey JA, Ouattara A, Coulibaly D, Lyke KE, Laurens MB, Pablo J, Jasinskas A, Nakajima R, Berry AA, Adams M, Jacob CG, Pike A, Takala-Harrison S, Liang L, Kouriba B, Kone AK, Rowe JA, Moulds J, Diallo DA, Doumbo OK, Thera MA, Felgner PL, Plowe CV.

Sci Rep. 2018 Apr 19;8(1):6281. doi: 10.1038/s41598-018-24462-4.

8.

Plasmodium vivax Infections of Duffy-Negative Erythrocytes: Historically Undetected or a Recent Adaptation?

Gunalan K, Niangaly A, Thera MA, Doumbo OK, Miller LH.

Trends Parasitol. 2018 May;34(5):420-429. doi: 10.1016/j.pt.2018.02.006. Epub 2018 Mar 9. Review.

9.

Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children.

Arama C, Diarra I, Kouriba B, Sirois F, Fedoryak O, Thera MA, Coulibaly D, Lyke KE, Plowe CV, Chrétien M, Doumbo OK, Mbikay M.

PLoS One. 2018 Feb 15;13(2):e0192850. doi: 10.1371/journal.pone.0192850. eCollection 2018.

10.

Interaction between environment, nutrient-derived metabolites and immunity: A possible role in malaria susceptibility/resistance in Fulani and Dogon of Mali.

Traore K, Thera MA, Bienvenu AL, Arama C, Bonnot G, Lavoignat A, Doumbo OK, Picot S.

PLoS One. 2017 Dec 20;12(12):e0189724. doi: 10.1371/journal.pone.0189724. eCollection 2017.

11.

Spatio-Temporal Dynamics of Asymptomatic Malaria: Bridging the Gap Between Annual Malaria Resurgences in a Sahelian Environment.

Coulibaly D, Travassos MA, Tolo Y, Laurens MB, Kone AK, Traore K, Sissoko M, Niangaly A, Diarra I, Daou M, Guindo B, Rebaudet S, Kouriba B, Dessay N, Piarroux R, Plowe CV, Doumbo OK, Thera MA, Gaudart J.

Am J Trop Med Hyg. 2017 Dec;97(6):1761-1769. doi: 10.4269/ajtmh.17-0074. Epub 2017 Oct 19.

12.

Plasmodium vivax Infections over 3 Years in Duffy Blood Group Negative Malians in Bandiagara, Mali.

Niangaly A, Karthigayan Gunalan, Amed Ouattara, Coulibaly D, Sá JM, Adams M, Travassos MA, Ferrero J, Laurens MB, Kone AK, Thera MA, Plowe CV, Miller LH, Doumbo OK.

Am J Trop Med Hyg. 2017 Sep;97(3):744-752. doi: 10.4269/ajtmh.17-0254. Epub 2017 Jul 27.

13.

New var reconstruction algorithm exposes high var sequence diversity in a single geographic location in Mali.

Dara A, Drábek EF, Travassos MA, Moser KA, Delcher AL, Su Q, Hostelley T, Coulibaly D, Daou M, Dembele A, Diarra I, Kone AK, Kouriba B, Laurens MB, Niangaly A, Traore K, Tolo Y, Fraser CM, Thera MA, Djimde AA, Doumbo OK, Plowe CV, Silva JC.

Genome Med. 2017 Mar 28;9(1):30. doi: 10.1186/s13073-017-0422-4.

14.

Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine.

Laurens MB, Kouriba B, Bergmann-Leitner E, Angov E, Coulibaly D, Diarra I, Daou M, Niangaly A, Blackwelder WC, Wu Y, Cohen J, Ballou WR, Vekemans J, Lanar DE, Dutta S, Diggs C, Soisson L, Heppner DG, Doumbo OK, Plowe CV, Thera MA.

PLoS One. 2017 Mar 10;12(3):e0173294. doi: 10.1371/journal.pone.0173294. eCollection 2017.

15.

Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.

Clarke GM, Rockett K, Kivinen K, Hubbart C, Jeffreys AE, Rowlands K, Jallow M, Conway DJ, Bojang KA, Pinder M, Usen S, Sisay-Joof F, Sirugo G, Toure O, Thera MA, Konate S, Sissoko S, Niangaly A, Poudiougou B, Mangano VD, Bougouma EC, Sirima SB, Modiano D, Amenga-Etego LN, Ghansah A, Koram KA, Wilson MD, Enimil A, Evans J, Amodu OK, Olaniyan S, Apinjoh T, Mugri R, Ndi A, Ndila CM, Uyoga S, Macharia A, Peshu N, Williams TN, Manjurano A, Sepúlveda N, Clark TG, Riley E, Drakeley C, Reyburn H, Nyirongo V, Kachala D, Molyneux M, Dunstan SJ, Phu NH, Quyen NN, Thai CQ, Hien TT, Manning L, Laman M, Siba P, Karunajeewa H, Allen S, Allen A, Davis TM, Michon P, Mueller I, Molloy SF, Campino S, Kerasidou A, Cornelius VJ, Hart L, Shah SS, Band G, Spencer CC, Agbenyega T, Achidi E, Doumbo OK, Farrar J, Marsh K, Taylor T, Kwiatkowski DP; MalariaGEN Consortium.

Elife. 2017 Jan 9;6. pii: e15085. doi: 10.7554/eLife.15085.

16.

Epidemiology of the outbreak, vectors and reservoirs of cutaneous leishmaniasis in Mali: A systematic review and meta-analysis.

Kone AK, Niare DS, Thera MA, Kayentao K, Djimde A, Delaunay P, Kouriba B, Giudice PD, Izri A, Marty P, Doumbo OK.

Asian Pac J Trop Med. 2016 Oct;9(10):985-990. doi: 10.1016/j.apjtm.2016.07.025. Epub 2016 Aug 20.

17.

Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara.

Thera MA, Coulibaly D, Kone AK, Guindo AB, Traore K, Sall AH, Diarra I, Daou M, Traore IM, Tolo Y, Sissoko M, Niangaly A, Arama C, Baby M, Kouriba B, Sissoko MS, Sagara I, Toure OB, Dolo A, Diallo DA, Remarque E, Chilengi R, Noor R, Sesay S, Thomas A, Kocken CH, Faber BW, Imoukhuede EB, Leroy O, Doumbo OK.

Malar J. 2016 Aug 30;15(1):442. doi: 10.1186/s12936-016-1466-4.

18.

Genetic diversity of Plasmodium falciparum in human malaria cases in Mali.

Nabet C, Doumbo S, Jeddi F, Konaté S, Manciulli T, Fofana B, L'Ollivier C, Camara A, Moore S, Ranque S, Théra MA, Doumbo OK, Piarroux R.

Malar J. 2016 Jul 11;15:353. doi: 10.1186/s12936-016-1397-0.

19.

Dermatophytosis among Schoolchildren in Three Eco-climatic Zones of Mali.

Coulibaly O, Kone AK, Niaré-Doumbo S, Goïta S, Gaudart J, Djimdé AA, Piarroux R, Doumbo OK, Thera MA, Ranque S.

PLoS Negl Trop Dis. 2016 Apr 28;10(4):e0004675. doi: 10.1371/journal.pntd.0004675. eCollection 2016 Apr.

20.

Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate.

Graves SF, Kouriba B, Diarra I, Daou M, Niangaly A, Coulibaly D, Keita Y, Laurens MB, Berry AA, Vekemans J, Ripley Ballou W, Lanar DE, Dutta S, Gray Heppner D, Soisson L, Diggs CL, Thera MA, Doumbo OK, Plowe CV, Sztein MB, Lyke KE.

Vaccine. 2016 May 17;34(23):2546-55. doi: 10.1016/j.vaccine.2016.04.019. Epub 2016 Apr 15.

PMID:
27087149
21.

Expression of complement and toll-like receptor pathway genes is associated with malaria severity in Mali: a pilot case control study.

Sobota RS, Dara A, Manning JE, Niangaly A, Bailey JA, Kone AK, Thera MA, Djimdé AA, Vernet G, Leissner P, Williams SM, Plowe CV, Doumbo OK.

Malar J. 2016 Mar 9;15:150. doi: 10.1186/s12936-016-1189-6.

22.

Correction: Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications.

Gandhi K, Thera MA, Coulibaly D, Traoré K, Guindo AB, Ouattara A, Takala-Harrison S, Berry AA, Doumbo OK, Plowe CV.

PLoS One. 2016 Jan 28;11(1):e0148240. doi: 10.1371/journal.pone.0148240. eCollection 2016.

23.

Understandings of genomic research in developing countries: a qualitative study of the views of MalariaGEN participants in Mali.

Traore K, Bull S, Niare A, Konate S, Thera MA, Kwiatkowski D, Parker M, Doumbo OK.

BMC Med Ethics. 2015 Jun 16;16:42. doi: 10.1186/s12910-015-0035-7.

24.

[Lice in Mali: frequency of infestation, genotyping, infection rate and case management].

Sangaré AK, Doumbo SN, Koné AK, Thera MA, Dabo A, Brouqui P, Raoult D, Doumbo OK.

Med Sante Trop. 2015 Apr-Jun;25(2):189-93. doi: 10.1684/mst.2015.0442. French.

25.

Hemoglobin C Trait Provides Protection From Clinical Falciparum Malaria in Malian Children.

Travassos MA, Coulibaly D, Laurens MB, Dembélé A, Tolo Y, Koné AK, Traoré K, Niangaly A, Guindo A, Wu Y, Berry AA, Jacob CG, Takala-Harrison S, Adams M, Shrestha B, Mu AZ, Kouriba B, Lyke KE, Diallo DA, Doumbo OK, Plowe CV, Thera MA.

J Infect Dis. 2015 Dec 1;212(11):1778-86. doi: 10.1093/infdis/jiv308. Epub 2015 May 27.

26.

Polymorphisms in the K13-propeller gene in artemisinin-susceptible Plasmodium falciparum parasites from Bougoula-Hameau and Bandiagara, Mali.

Ouattara A, Kone A, Adams M, Fofana B, Maiga AW, Hampton S, Coulibaly D, Thera MA, Diallo N, Dara A, Sagara I, Gil JP, Bjorkman A, Takala-Harrison S, Doumbo OK, Plowe CV, Djimde AA.

Am J Trop Med Hyg. 2015 Jun;92(6):1202-6. doi: 10.4269/ajtmh.14-0605. Epub 2015 Apr 27.

27.

Differential recognition of terminal extracellular Plasmodium falciparum VAR2CSA domains by sera from multigravid, malaria-exposed Malian women.

Travassos MA, Coulibaly D, Bailey JA, Niangaly A, Adams M, Nyunt MM, Ouattara A, Lyke KE, Laurens MB, Pablo J, Jasinskas A, Nakajima R, Berry AA, Takala-Harrison S, Kone AK, Kouriba B, Rowe JA, Doumbo OK, Thera MA, Laufer MK, Felgner PL, Plowe CV.

Am J Trop Med Hyg. 2015 Jun;92(6):1190-1194. doi: 10.4269/ajtmh.14-0524. Epub 2015 Apr 27.

28.

A double-blind randomized placebo-controlled clinical trial of squalamine ointment for tinea capitis treatment.

Coulibaly O, Thera MA, Koné AK, Siaka G, Traoré P, Djimdé AA, Brunel JM, Gaudart J, Piarroux R, Doumbo OK, Ranque S.

Mycopathologia. 2015 Apr;179(3-4):187-93. doi: 10.1007/s11046-014-9849-y. Epub 2014 Dec 17.

PMID:
25515244
29.

High dermatophyte contamination levels in hairdressing salons of a West African suburban community.

Coulibaly O, Thera MA, Piarroux R, Doumbo OK, Ranque S.

Mycoses. 2015 Feb;58(2):65-8. doi: 10.1111/myc.12272. Epub 2014 Nov 11.

PMID:
25385435
30.

Seroreactivity to a large panel of field-derived Plasmodium falciparum apical membrane antigen 1 and merozoite surface protein 1 variants reflects seasonal and lifetime acquired responses to malaria.

Bailey JA, Pablo J, Niangaly A, Travassos MA, Ouattara A, Coulibaly D, Laurens MB, Takala-Harrison SL, Lyke KE, Skinner J, Berry AA, Jasinskas A, Nakajima-Sasaki R, Kouriba B, Thera MA, Felgner PL, Doumbo OK, Plowe CV.

Am J Trop Med Hyg. 2015 Jan;92(1):9-12. doi: 10.4269/ajtmh.14-0140. Epub 2014 Oct 6.

31.

Stable malaria incidence despite scaling up control strategies in a malaria vaccine-testing site in Mali.

Coulibaly D, Travassos MA, Kone AK, Tolo Y, Laurens MB, Traore K, Diarra I, Niangaly A, Daou M, Dembele A, Sissoko M, Guindo B, Douyon R, Guindo A, Kouriba B, Sissoko MS, Sagara I, Plowe CV, Doumbo OK, Thera MA.

Malar J. 2014 Sep 19;13:374. doi: 10.1186/1475-2875-13-374.

32.

Variation in the circumsporozoite protein of Plasmodium falciparum: vaccine development implications.

Gandhi K, Thera MA, Coulibaly D, Traoré K, Guindo AB, Ouattara A, Takala-Harrison S, Berry AA, Doumbo OK, Plowe CV.

PLoS One. 2014 Jul 3;9(7):e101783. doi: 10.1371/journal.pone.0101783. eCollection 2014. Erratum in: PLoS One. 2016;11(1):e0148240.

33.

Preliminary study of the fungal ecology at the haematology and medical-oncology ward in Bamako, Mali.

Niaré-Doumbo S, Normand AC, Diallo YL, Dembelé AK, Thera MA, Diallo D, Piarroux R, Doumbo O, Ranque S.

Mycopathologia. 2014 Aug;178(1-2):103-9. doi: 10.1007/s11046-014-9760-6. Epub 2014 Jun 3.

PMID:
24889723
34.

Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trial.

Laurens MB, Thera MA, Coulibaly D, Ouattara A, Kone AK, Guindo AB, Traore K, Traore I, Kouriba B, Diallo DA, Diarra I, Daou M, Dolo A, Tolo Y, Sissoko MS, Niangaly A, Sissoko M, Takala-Harrison S, Lyke KE, Wu Y, Blackwelder WC, Godeaux O, Vekemans J, Dubois MC, Ballou WR, Cohen J, Dube T, Soisson L, Diggs CL, House B, Bennett JW, Lanar DE, Dutta S, Heppner DG, Plowe CV, Doumbo OK.

PLoS One. 2013 Nov 18;8(11):e79323. doi: 10.1371/journal.pone.0079323. eCollection 2013.

35.

[Malian first observation of disseminated African histoplasmosis with predominant bone localizations in an HIV-negative child in Bamako (Mali). Review of the literature].

Minta DK, Sylla M, Traoré AM, Soukho-Kaya A, Coulibaly I, Diallo K, Théra MA, Sidibé AT, Sidibé S, Traoré HA, Pichard E, Chabasse D.

J Mycol Med. 2014 Jun;24(2):152-7. doi: 10.1016/j.mycmed.2013.08.001. Epub 2013 Oct 2. Review. French.

PMID:
24094479
36.

Seroreactivity to Plasmodium falciparum erythrocyte membrane protein 1 intracellular domain in malaria-exposed children and adults.

Travassos MA, Niangaly A, Bailey JA, Ouattara A, Coulibaly D, Laurens MB, Pablo J, Jasinskas A, Nakajima-Sasaki R, Berry AA, Takala-Harrison S, Kouriba B, Rowe JA, Lyke KE, Doumbo OK, Thera MA, Felgner PL, Plowe CV.

J Infect Dis. 2013 Nov 1;208(9):1514-9. doi: 10.1093/infdis/jit339. Epub 2013 Jul 30.

37.

Spatio-temporal analysis of malaria within a transmission season in Bandiagara, Mali.

Coulibaly D, Rebaudet S, Travassos M, Tolo Y, Laurens M, Kone AK, Traore K, Guindo A, Diarra I, Niangaly A, Daou M, Dembele A, Sissoko M, Kouriba B, Dessay N, Gaudart J, Piarroux R, Thera MA, Plowe CV, Doumbo OK.

Malar J. 2013 Mar 1;12:82. doi: 10.1186/1475-2875-12-82.

38.

Plasmodium vivax malaria in Mali: a study from three different regions.

Bernabeu M, Gomez-Perez GP, Sissoko S, Niambélé MB, Haibala AA, Sanz A, Théra MA, Fernandez-Becerra C, Traoré K, Alonso PL, Bassat Q, Del Portillo HA, Doumbo O.

Malar J. 2012 Dec 5;11:405. doi: 10.1186/1475-2875-11-405.

39.

Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications.

Ouattara A, Takala-Harrison S, Thera MA, Coulibaly D, Niangaly A, Saye R, Tolo Y, Dutta S, Heppner DG, Soisson L, Diggs CL, Vekemans J, Cohen J, Blackwelder WC, Dube T, Laurens MB, Doumbo OK, Plowe CV.

J Infect Dis. 2013 Feb 1;207(3):511-9. doi: 10.1093/infdis/jis709. Epub 2012 Nov 29.

40.

In vitro activity of aminosterols against dermatophytes.

Coulibaly O, Alhanout K, L'Ollivier C, Brunel JM, Thera MA, Djimdé AA, Doumbo OK, Piarroux R, Ranque S.

Med Mycol. 2013 Apr;51(3):309-12. doi: 10.3109/13693786.2012.724773. Epub 2012 Sep 24.

PMID:
22998181
41.

Candidate polymorphisms and severe malaria in a Malian population.

Toure O, Konate S, Sissoko S, Niangaly A, Barry A, Sall AH, Diarra E, Poudiougou B, Sepulveda N, Campino S, Rockett KA, Clark TG, Thera MA, Doumbo O; Collaboration with The MalariaGEN Consortium.

PLoS One. 2012;7(9):e43987. doi: 10.1371/journal.pone.0043987. Epub 2012 Sep 5.

42.

No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali.

Maiga AW, Fofana B, Sagara I, Dembele D, Dara A, Traore OB, Toure S, Sanogo K, Dama S, Sidibe B, Kone A, Thera MA, Plowe CV, Doumbo OK, Djimde AA.

Am J Trop Med Hyg. 2012 Jul;87(1):23-8. doi: 10.4269/ajtmh.2012.12-0058.

43.

Next generation sequencing to detect variation in the Plasmodium falciparum circumsporozoite protein.

Gandhi K, Thera MA, Coulibaly D, Traoré K, Guindo AB, Doumbo OK, Takala-Harrison S, Plowe CV.

Am J Trop Med Hyg. 2012 May;86(5):775-81. doi: 10.4269/ajtmh.2012.11-0478.

44.

First detection of Leishmania major DNA in Sergentomyia (Spelaeomyia) darlingi from cutaneous leishmaniasis foci in Mali.

Berdjane-Brouk Z, Koné AK, Djimdé AA, Charrel RN, Ravel C, Delaunay P, del Giudice P, Diarra AZ, Doumbo S, Goita S, Thera MA, Depaquit J, Marty P, Doumbo OK, Izri A.

PLoS One. 2012;7(1):e28266. doi: 10.1371/journal.pone.0028266. Epub 2012 Jan 20.

45.

[Epidemiology of cutaneous leishmaniasis in five villages of Dogon country, Mali].

Kone AK, Delaunay P, Djimdé AA, Thera MA, Giudice PD, Coulibaly D, Traoré K, Goita SM, Abathina A, Izri A, Marty P, Doumbo OK.

Bull Soc Pathol Exot. 2012 Feb;105(1):8-15. doi: 10.1007/s13149-011-0194-9. Epub 2012 Jan 13. French.

PMID:
22246557
46.

Use of a pLDH-based dipstick in the diagnostic and therapeutic follow-up of malaria patients in Mali.

Ouattara A, Doumbo S, Saye R, Beavogui AH, Traoré B, Djimdé A, Niangaly A, Kayentao K, Diallo M, Doumbo OK, Thera MA.

Malar J. 2011 Nov 24;10:345. doi: 10.1186/1475-2875-10-345.

47.

Vaccines for malaria: how close are we?

Thera MA, Plowe CV.

Annu Rev Med. 2012;63:345-57. doi: 10.1146/annurev-med-022411-192402. Epub 2011 Nov 10. Review.

48.

A field trial to assess a blood-stage malaria vaccine.

Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Ouattara A, Kone AK, Guindo AB, Traore K, Traore I, Kouriba B, Diallo DA, Diarra I, Daou M, Dolo A, Tolo Y, Sissoko MS, Niangaly A, Sissoko M, Takala-Harrison S, Lyke KE, Wu Y, Blackwelder WC, Godeaux O, Vekemans J, Dubois MC, Ballou WR, Cohen J, Thompson D, Dube T, Soisson L, Diggs CL, House B, Lanar DE, Dutta S, Heppner DG Jr, Plowe CV.

N Engl J Med. 2011 Sep 15;365(11):1004-13. doi: 10.1056/NEJMoa1008115.

49.

Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali.

Kone AK, Sagara I, Thera MA, Dicko A, Guindo A, Diakite S, Kurantsin-Mills J, Djimde A, Walcourt A, Doumbo O.

Malar J. 2010 Nov 21;9:332. doi: 10.1186/1475-2875-9-332.

50.

[Immunity in human schistosomiasis: hope for a vaccine].

Kouriba B, Traore B, Diemert D, Thera MA, Dolo A, Tounkara A, Doumbo O.

Med Trop (Mars). 2010 Apr;70(2):189-97. Review. French.

PMID:
20486361

Supplemental Content

Loading ...
Support Center